BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37432852)

  • 61. Intrahepatic Carcinosarcoma With Cholangiocarcinoma Elements and Prominent Bile Duct Spread.
    Usui G; Hashimoto H; Kusakabe M; Shirota G; Sugiura Y; Fujita Y; Satou S; Harihara Y; Horiuchi H; Morikawa T
    Int J Surg Pathol; 2019 Dec; 27(8):900-906. PubMed ID: 31203684
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biliary tumors of the liver.
    Colombari R; Tsui WM
    Semin Liver Dis; 1995 Nov; 15(4):402-13. PubMed ID: 8578323
    [No Abstract]   [Full Text] [Related]  

  • 63. Regulators of apoptosis in cholangiocarcinoma.
    Jhala NC; Vickers SM; Argani P; McDonald JM
    Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expression of tenascin, type IV collagen and laminin during human intrahepatic bile duct development and in intrahepatic cholangiocarcinoma.
    Terada T; Nakanuma Y
    Histopathology; 1994 Aug; 25(2):143-50. PubMed ID: 7527010
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Clinical pathology of cholangiocarcinoma (intrahepatic bile duct cancer)].
    Yamamoto M
    Nihon Geka Hokan; 1995 Nov; 64(6):129-30. PubMed ID: 8913088
    [No Abstract]   [Full Text] [Related]  

  • 66. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cytological diagnosis of biliary cryptococcosis in an immunocompromised patient with mid common bile duct stricture masquerading as cholangiocarcinoma.
    Burad DK; Ramakrishna B
    Cytopathology; 2017 Apr; 28(2):164-167. PubMed ID: 27592857
    [No Abstract]   [Full Text] [Related]  

  • 68. Intrahepatic cholangiocarcinoma arising in multiple bile duct hamartomas: report of two cases and review of the literature.
    Xu AM; Xian ZH; Zhang SH; Chen XF
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):580-4. PubMed ID: 19282767
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Primary biliary malignant lymphoma clinically mimicking cholangiocarcinoma: a case report and review of the literature.
    Eliason SC; Grosso LE
    Ann Diagn Pathol; 2001 Feb; 5(1):25-33. PubMed ID: 11172204
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hilar cholangiocarcinoma: pathology and tumor biology.
    Kuang D; Wang GP
    Front Med China; 2010 Dec; 4(4):371-7. PubMed ID: 21110142
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Congenital dilatation of the intrahepatic bile ducts with cholangiocarcinoma.
    Gallagher PJ; Millis RR; Mitchinson MJ
    J Clin Pathol; 1972 Sep; 25(9):804-8. PubMed ID: 4343747
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Pathology of gallbladder and extrahepatic bile ducts. Case 6. Well- differentiated hilar cholangiocarcinoma pT2bN1].
    Guettier C
    Ann Pathol; 2014 Aug; 34(4):309-14. PubMed ID: 25132442
    [No Abstract]   [Full Text] [Related]  

  • 73. Awareness of tract seeding with endoscopic ultrasound tissue acquisition in perihilar cholangiocarcinoma.
    Razumilava N; Gleeson FC; Gores GJ
    Am J Gastroenterol; 2015 Jan; 110(1):200. PubMed ID: 25567184
    [No Abstract]   [Full Text] [Related]  

  • 74. Intraductal growth-type mucin-producing peripheral cholangiocarcinoma associated with biliary papillomatosis.
    Güllüoglu MG; Ozden I; Poyanli A; Cevikbas U; Ariogul O
    Ann Diagn Pathol; 2007 Feb; 11(1):34-8. PubMed ID: 17240305
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Carcinoma of the cystic duct remnant with direct colonic invasion.
    Noji T; Kondo S; Hirano S; Ambo Y; Tanaka E; Okushiba S; Katoh H
    Int J Gastrointest Cancer; 2003; 34(2-3):117-20. PubMed ID: 15361644
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma.
    Saito Y; Muramatsu T; Kanai Y; Ojima H; Sukeda A; Hiraoka N; Arai E; Sugiyama Y; Matsuzaki J; Uchida R; Yoshikawa N; Furukawa R; Saito H
    Cell Rep; 2019 Apr; 27(4):1265-1276.e4. PubMed ID: 31018139
    [TBL] [Abstract][Full Text] [Related]  

  • 77. CT features of intraductal intrahepatic cholangiocarcinoma.
    Lee JW; Han JK; Kim TK; Kim YH; Choi BI; Han MC; Suh KS; Kim SW
    AJR Am J Roentgenol; 2000 Sep; 175(3):721-5. PubMed ID: 10954456
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cholangiocarcinoma and brain lesions: an extremely rare finding.
    Mirrakhimov AE; Nwankwo N; Zdunek T; Bucher N
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23667219
    [No Abstract]   [Full Text] [Related]  

  • 79. Highlights of topic "new trends on pathology of cholangiocarcinoma".
    Nakanuma Y
    J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):439-40. PubMed ID: 24942377
    [No Abstract]   [Full Text] [Related]  

  • 80. Total necrosis of rapid growing hilar cholangiocarcinoma.
    Cha IH; Kim JN; Oh MK; Ryu SH; Kim YS; Moon JS; Lee HK
    Gastrointest Endosc; 2013 Jun; 77(6):956-7; discussion 957-8. PubMed ID: 23522022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.